检索

期
标题
作者
卷 92, 编号 4 (2020)
Evaluation of the effectiveness of ultrasound shear elastography and liver steatometry
Tarasova O., Kuhareva E., Krasnitskaya S., Mazurchik N., Ngameni M., Malinina N., Zykin B., Ogurtsov P.
PDF
(Rus)
卷 88, 编号 2 (2016)
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
Drapkina O., Zyatenkova E.
PDF
(Rus)
卷 88, 编号 2 (2016)
A new non-invasive method for assessing steatosis in chronic liver diseases
Bakulin I., Sandler Y., Keyan V., Rotin D.
PDF
(Rus)
卷 96, 编号 2 (2024)
Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study)
Vinnitskaya E., Sandler Y., Saliev K., Ivanov A., Sbikina E., Khaymenova T., Bordin D.
PDF
(Rus)
卷 92, 编号 8 (2020)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
PDF
(Rus)
卷 92, 编号 12 (2020)
Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease
Vakhrushev Y., Suchkova E., Lukashevich А.
PDF
(Rus)
卷 86, 编号 8 (2014)
Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance
Tkachenko L., Maleev V.
卷 84, 编号 11 (2012)
Hepatitis C virus Genotype 3: that "simple", yet that "complex"
Batskikh S., Morozov S., Chulanov V., Pokrovskiĭ V.
卷 93, 编号 2 (2021)
Molecular factors associated with regression of liver fibrosis of alcoholic etiology
Kiseleva Y., Zharikov Y., Maslennikov R., Pavlov C., Nikolenko V.
PDF
(Rus)
卷 86, 编号 10 (2014)
The problem of viral hepatitis C in the Russian Federation
Iushchuk N., Znoĭko O., Dudina K., Belyĭ P.
卷 88, 编号 4 (2016)
The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C
Andreev D., Maev I., Kucheryavyi Y., Dicheva D., Partsvania-vinogradova E.
PDF
(Rus)
卷 89, 编号 2 (2017)
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
Bakulin I., Sandler Y., Vinnitskayа E., Keiyan V., Rodionova S., Rotin D.
PDF
(Rus)
卷 84, 编号 11 (2012)
A histological response to antiviral therapy for chronic hepatitis C in patients who failed to achieve a sustained virological response
Riumin A., Korochkina O.
卷 96, 编号 2 (2024)
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
PDF
(Rus)
卷 93, 编号 11 (2021)
Functional activity of blood neutrophilic granulocytes in patients with opisthorchiasis, depending on the severity of liver fibrosis
Tsukanov V., Gorchilova E., Kolenchukova O., Gvozdev I., Savchenko A., Kasparov E., Vasyutin A., Tonkikh J., Borisov A., Rzhavicheva O.
PDF
(Rus)
卷 86, 编号 4 (2014)
Alcoholic liver disease: State-of-the-art
Maev I., Abdurakhmanov D., Andreev D., Dicheva D.
卷 94, 编号 2 (2022)
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
PDF
(Rus)
卷 90, 编号 2 (2018)
Intrahepatic cholestasis in nonalcoholic fatty liver disease
Shipovskaya A., Dudanova O.
PDF
(Rus)
卷 88, 编号 12 (2016)
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
Livzan M., Akhmedov V., Krolevets T., Gaus O., Cherkaschenko N.
PDF
(Rus)
卷 88, 编号 11 (2016)
Insulin resistance and chronic hepatitis C
Tkachenko L., Maleev V.
PDF
(Rus)
卷 82, 编号 10 (2010)
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C
Bayzhanova Z., Ignatova T., Nekrasova T., Baizhanova Z., Ignatova T., Nekrasova T.
卷 89, 编号 11 (2017)
Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis
Kalyuzhin O., Ponezheva Z., Semenova I., Khokhlova O., Serebrovskaya L., Guseva T., Parshina O., Maleev V.
PDF
(Rus)
卷 86, 编号 10 (2014)
Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Drapkina O., Deeva T., Volkova N., Ivashkin V.
卷 93, 编号 2 (2021)
Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C
Kovalevа V., Zhevnerova N., Antonova T.
PDF
(Rus)
卷 92, 编号 2 (2020)
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
Maev I., Kuznetsova E., Andreev D., Dicheva D.
PDF
(Rus)
卷 95, 编号 2 (2023)
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases
Sbikina E., Vinnitskaya E., Batskikh S., Sandler Y., Saliev K., Khaimenova T., Bordin D.
PDF
(Rus)
卷 85, 编号 2 (2013)
Diagnostic value of serum markers of fibrosis in chronic liver diseases
Vinnitskaia E., Drozdov V., Iunusova I., Varvanina G., Shaposhnikova N., Petrakov A., Tkachenko E., Lazebnik L.
1 - 27 的 27 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##